Journal article
Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia
Nature communications, Vol.8(1), 14175
02/06/2017
DOI: 10.1038/ncomms14175
PMCID: PMC5303820
PMID: 28165464
Abstract
Several chronic lymphocytic leukaemia (CLL) susceptibility loci have been reported; however, much of the heritable risk remains unidentified. Here we perform a meta-analysis of six genome-wide association studies, imputed using a merged reference panel of 1,000 Genomes and UK10K data, totalling 6,200 cases and 17,598 controls after replication. We identify nine risk loci at 1p36.11 (rs34676223, P = 5.04 X 10 (-) (13)), 1q42.13 (rs41271473, P = 1.06 X 10 (-) (10)), 4q24 (rs71597109, P = 1.37 X 10 (-) (10)), 4q35.1 (rs57214277, P = 3.69 X 10 (-) (8)), 6p21.31 (rs3800461, P = 1.97 X 10 (-) (8)), 11q23.2 (rs61904987, P = 2.64 X 10 (-) (11)), 18q21.1 (rs1036935, P = 3.27 X 10 (-) (8)), 19p13.3 (rs7254272, P = 4.67 X 10 (-) (8)) and 22q13.33 (rs140522, P = 2.70 X 10 (-) (9)). These new and established risk loci map to areas of active chromatin and show an over-representation of transcription factor binding for the key determinants of B-cell development and immune response.
Details
- Title: Subtitle
- Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia
- Creators
- Phillip J. Law - Inst Canc Res, Div Genet & Epidemiol, London SW7 3RP, EnglandSonja I. Berndt - National Institutes of HealthHelen E. Speedy - Inst Canc Res, Div Genet & Epidemiol, London SW7 3RP, EnglandNicola J. Camp - University of UtahGeorgina P. Sava - Inst Canc Res, Div Genet & Epidemiol, London SW7 3RP, EnglandChristine F. Skibola - University of Alabama at BirminghamAmy Holroyd - Microsoft (United States)Vijai Joseph - Memorial Sloan Kettering Cancer CenterNicola J. Sunter - Newcastle UniversityAlexandra Nieters - University of FreiburgSilvia Bea - Universitat de BarcelonaAlain Monnereau - Délégation Paris 5David Martin-Garcia - Universitat de BarcelonaLynn R. Goldin - National Institutes of HealthGuillem Clot - Pi (United Kingdom)Lauren R. Teras - American Cancer SocietyInes Quintela - Universidade de Santiago de CompostelaBrenda M. Birmann - Harvard UniversitySandrine Jayne - University of LeicesterWendy Cozen - University of Southern CaliforniaAneela Majid - University of AleppoKarin E. Smedby - Karolinska InstitutetQing Lan - National Institutes of HealthClaire Dearden - Royal Marsden NHS Foundation TrustAngela R. Brooks-Wilson - Simon Fraser UniversityAndrew G. Hall - Newcastle UniversityMark P. Purdue - National Institutes of HealthTryfonia Mainou-Fowler - Newcastle UniversityClaire M. Vajdic - UNSW SydneyGraham H. Jackson - Royal Victoria Infirm, Dept Haematol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, EnglandPierluigi Cocco - University of CagliariHelen Marr - Newcastle UniversityYawei Zhang - Yale Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT 06520 USATongzhang Zheng - Yale UniversityGraham G. Giles - Cancer Council VictoriaCharles Lawrence - University of OuluTimothy G. Call - Mayo ClinicMark Liebow - Mayo Clinic in FloridaMads Melbye - Stanford UniversityBengt Glimelius - Uppsala UniversityLarry Mansouri - Uppsala UniversityMartha Glenn - Université Paris CitéKaren Curtin - University of UtahW. Ryan Diver - American Cancer SocietyBrian K. Link - University of IowaLucia Conde - University of Alabama at BirminghamPaige M. Bracci - University of California, San FranciscoElizabeth A. Holly - University of California, San FranciscoRebecca D. Jackson - The Ohio State UniversityLesley F. Tinker - Fred Hutch Cancer CenterYolanda Benavente - Universitat de BarcelonaPaolo Boffetta - Icahn School of Medicine at Mount SinaiPaul Brennan - Centre international de recherche sur le cancerMarc Maynadie - Université de BourgogneJames McKay - Centre international de recherche sur le cancerDemetrius Albanes - National Institutes of HealthStephanie Weinstein - National Institutes of HealthZhaoming Wang - St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USANeil E. Caporaso - National Institutes of HealthLindsay M. Morton - National Institutes of HealthRichard K. Severson - Wayne State UniversityElio Riboli - Imperial College LondonPaolo Vineis - Imperial College LondonRoel C. H. Vermeulen - TD Bank GroupMelissa C. Southey - The University of MelbourneRoger L. Milne - The University of MelbourneJacqueline Clavel - Institut de Radioprotection et de Sûreté NucléaireSabine Topka - Memorial Sloan Kettering Cancer CenterJohn J. Spinelli - University of British ColumbiaPeter Kraft - Harvard UniversityMaria Grazia Ennas - University of CagliariGeoffrey Summerfield - Queen Elizabeth Hosp, Dept Haematol, Gateshead NE9 6SX, EnglandGiovanni M. Ferri - University of Bari Aldo MoroRobert J. Harris - Pennsylvania State UniversityLucia Miligi - Florence (Netherlands)Andrew R. Pettitt - University of LiverpoolKari E. North - University of North Carolina at Chapel HillDavid J. Allsup - Newcastle UniversityJoseph F. Fraumeni - National Institutes of HealthJames R. Bailey - University of Newcastle AustraliaKenneth Offit - Memorial Sloan Kettering Cancer CenterGuy Pratt - Birmingham Heartlands Hosp, Dept Haematol, Birmingham B9 5SS, W Midlands, EnglandHenrik Hjalgrim - Statens Serum InstitutChris Pepper - Cardiff UniversityStephen J. Chanock - National Institutes of HealthChris Fegan - Cardiff & Vale Natl Hlth Serv Trust, Heath Pk, Cardiff CF14 4XW, S Glam, WalesRichard Rosenquist - Uppsala UniversitySilvia de Sanjose - Centre international de recherche sur le cancerAngel Carracedo - Universidade de Santiago de CompostelaMartin J. S. Dyer - University of LeedsDaniel Catovsky - Inst Canc Res, Div Mol Pathol, London SW7 3RP, EnglandElias Campo - Universitat de BarcelonaJames R. Cerhan - Mayo Clinic in FloridaJames M. Allan - Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, EnglandNathanial Rothman - National Institutes of HealthRichard Houlston - Inst Canc Res, Div Genet & Epidemiol, London SW7 3RP, EnglandSusan L. Slager - Mayo Clinic in Florida
- Resource Type
- Journal article
- Publication Details
- Nature communications, Vol.8(1), 14175
- DOI
- 10.1038/ncomms14175
- PMID
- 28165464
- PMCID
- PMC5303820
- NLM abbreviation
- Nat Commun
- ISSN
- 2041-1723
- eISSN
- 2041-1723
- Publisher
- Springer Nature
- Number of pages
- 12
- Grant note
- N01 CN 45165; N01 RC 45035; N01 RC 37004; HHSN261201000006C / U.S. Public Health Service from the National Cancer Institute, Department of Health and Human Services; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) National Cancer Institute; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) QLK4-CT-2000-00422; FOOD-CT-2006-023103 / EpiLymph-European Commission Leukemia and Lymphoma Society Career Development Award; Leukemia and Lymphoma Society 209057; 251553; 504711 / Australian NHMRC; National Health and Medical Research Council (NHMRC) of Australia P30CA042014; P30CA086862; P30CA015083; R01CA148690; U01CA049449; P50CA097274; U01CA118444; R03CA089745; R01CA154643; R01CA045614; R01CA092153; R21CA178800; UM1CA186107; K08CA134919; R01CA149445; P30CA016087; R01CA098661; R21CA165923; R01CA098122; R01CA049449; P01CA087969; R01CA062006; UM1CA167552; R01CA087014; R01CA134674 / NATIONAL CANCER INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) Association de Recherche Contre le Cancer; Fondation ARC pour la Recherche sur le Cancer P50 CA97274 / Iowa-Mayo SPORE-NCI Specialized Programs of Research Excellence (SPORE) in Human Cancer 2014SRG756 / Agencia de Gestiod AjutsUniversitarisi de Recerca-Generalitat de Catalunya; Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR); Generalitat de Catalunya 103885 / California Department of Health Services HHSN268201100046C; HHSN268201100001C; HHSN268201100002C; HHSN268201100003C; HHSN268201100004C; HHSN271201100004C / National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI) VicHealth Bernstein Family Fund for Leukemia and Lymphoma Research P30 CA42014 / HCI Comprehensive Cancer Center Support grant P30ES000260 / NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS) HHSN261201000140C; HHSN261201000035C; HHSN261201000034C / National Cancer Institute's Surveillance, Epidemiology and End Results Program; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) MC_U132670597 / MRC; UK Research & Innovation (UKRI); Medical Research Council UK (MRC) UL1 TR000135 / National Center for Advancing Translational Science KL2TR001862; UL1TR000135; UL1TR001863 / NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS) N01-PC-65064; N01-PC-67008; N01-PC-67009; N01-PC-67010; N02-PC-71105 / NCI-SEER-Intramural Research Program of the National Cancer Institute, National Institutes of Health and Public Health Service DJCLS-R12/23 / Jose Carreras Leukemia Foundation 11855 / Italian GxE-Italian Association for Cancer Research (AIRC); Fondazione AIRC per la ricerca sul cancro National Cancer Institute Surveillance Epidemiology and End Results program; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) Cancer Council Victoria; Canadian Institutes of Health Research (CIHR) 076113 / Wellcome Trust N01CN045165 / DIVISION OF CANCER PREVENTION AND CONTROL; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) Utah State Department of Health 051210 / Marato de TV3 Foundation 02 6661 / Swedish Cancer Society NO1-CO-12400 / NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA LRF05001; LRF06002; LRF13044 / United Kingdom, Bloodwise Institute of Cancer Research Cancer Council NSW; Cancer Council New South Wales University of Utah MC_U132670597 / Medical Research Council; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); European Commission intramural programme of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health 00209805 / MH CZ-DRO (MMCI) Arbib Fund University of Sydney Faculty of Medicine; University of Sydney 990920 / Australian National Health and Medical Research Council; National Health and Medical Research Council (NHMRC) of Australia U58DP000807 / NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO; United States Department of Health & Human Services; Centers for Disease Control & Prevention - USA Centers for Disease Control and Prevention National Program of Cancer Registries; United States Department of Health & Human Services; Centers for Disease Control & Prevention - USA Fondation de France Intramural Research Program of the National Cancer Institute; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) Intramural Research Program of the NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA CA1046282; CA154643; CA45614; CA89745; CA87014 / NCI, National Institutes of Health; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) PI11/01810; PI14/01219; RCESP C03/09; RTICESP C03/10; RTIC RD06/0020/0095; CIBERESP / Spanish Ministry of Health; Instituto de Salud Carlos III; Spanish Government 74419 / Barbara K. Lipman Lymphoma Research Fund U01HG007033 / NATIONAL HUMAN GENOME RESEARCH INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI) 1U58 DP000807-01 / Centers for Disease Control and Prevention's National Program of Cancer Registries; United States Department of Health & Human Services; Centers for Disease Control & Prevention - USA 006438; SP23-CT-2005-006438 / EPIC-Coordinated Action HHSN261201000026C / NIH from the National Cancer Institute SEER Program FIS PI13/01136 / Spanish Ministry of Economy and Competitiveness through the Instituto de Salud Carlos III C1298/A8362 / Cancer Research UK (Bobby Moore Fund) Intramural Research Program of the National Institutes of Health, NCI, Division of Cancer Epidemiology and Genetics StSch4261; StSch4420 / Federal Office for Radiation Protection K08CA134919; CA167552; CA149445; CA098122; CA186107; CA87969; CA49449 / National Institutes of Health; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA CZ.1.05/2.1.00/03.0101 / RECAMO Division of Cancer Prevention, National Cancer Institute, NIH, DHHS; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) American Cancer Society N01PC065064; N01PC067008; N01PC067010 / DIVISION OF CANCER CONTROL &POPULATION SCIENCE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Cancer Institute- Division of Cancer Control & Population Sciences
- Language
- English
- Date published
- 02/06/2017
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Epidemiology; Internal Medicine
- Record Identifier
- 9984359779902771
Metrics
14 Record Views